Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) and chloroform, and RNA integrity was assessed using the RNA Nano 6000 Assay Kit of ... were sequenced on an Illumina Novaseq ...

He noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...

The company made significant progress with the NovaSeq X transition, with 91 instruments placed during the quarter, bringing the installed base to 630. Illumina Inc (NASDAQ:ILMN) achieved more ...

Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable ...

Over the last six months, Angle has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for the ...

Illumina restored its profitability well ... which recently helped the stock to rebound from $100 to $150. While Free cash flow generation nicely rebounded in the S2 FY24, weaker than expected ...

Welcome to the fourth quarter 2024 Illumina earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over ...

Illumina (NASDAQ: ILMN) shares tumbled 16% this past week as investors reeled from a one-two punch of mixed fourth-quarter and full-year 2024 results, plus the prospect of losing all its revenue ...